Trial intelligence / Profile preview

Butyrate Enemas for Postoperative Intestinal Motility Disorders in Hirschsprung's Disease

NCT03660176Phase 3Not yet recruiting

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Nov 2026
Primary completion
May 2031
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sodium butyrate in Hirschsprung's disease (HSCR), sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

sodium butyrate
03

Conditions

Hirschsprung's disease (HSCR)

Beyond the preview

Go deeper on NCT03660176.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03660176.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call